Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

24-Mar-23 - 21-Mar-24
Buy Ratio:52%

Up

# Net Buyers:37
# Net Sellers:34

Previous 52 Weeks

25-Mar-22 - 23-Mar-23
Buy Ratio:37%
# Net Buyers:33
# Net Sellers:56
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Larimar Therapeutics, Inc.$38.00M$38.00M  
Dynavax Technologies Corp($21.58M)$22.46M  
Johnson & Johnson($6.84M)$17.05M  
Neurocrine Biosciences Inc$16.99M$16.44M  
Kalvista Pharmaceuticals, Inc.$12.70M$12.70M  
New Net Buyers
CompanyNet Buy AmountChange
Sarepta Therapeutics, Inc.$5.27M$5.28M  
Seagen Inc.$498.58K$2.59M  
Regeneron Pharmaceuticals, Inc.$1.69M$1.82M  
Ptc Therapeutics, Inc.$189.63K$1.13M  
Corcept Therapeutics Inc$192.60K$877.00K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Immunitybio, Inc.--($56.63M)  
Armata Pharmaceuticals, Inc.--($26.93M)  
Biomarin Pharmaceutical Inc($16.46M)($13.79M)  
Chinook Therapeutics, Inc.--($8.05M)  
Incyte Corp$46.54K($7.78M)  
New Net Sellers
CompanyNet Buy AmountChange
Gilead Sciences, Inc.($744.98K)($1.93M)  
Aldeyra Therapeutics, Inc.($107.07K)($122.09K)